Botulinum A toxin treatment for eyelid spasm, spasmodic torticollis and apraxia of eyelid opening

Botulinum toxin A injections improve apr

Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases

✍ Masato Kanazawa; Takayoshi Shimohata; Masahisa Sato; Osamu Onodera; Keiko Tanaka 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

Botulinum Toxin A Injections Improve Apraxia of Eyelid Opening without Overt Blepharospasm Associated with Neurodegenerative Diseases Apraxia of eyelid opening (AEO) designates an intermittent inability to open the eyes voluntarily. 1 AEO is observed in patients with neurodegenerative diseases, incl

Botulinum toxin A injections improve apr

Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases

✍ Eva Lopez Valdes; Ignacio Javier Posada Rodriguez; Rafael Bilbao-Calabuig 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

We have read with interest the letter of Kanazawa 1 about improvement of apraxia of eyelid opening (AEO) with botulinum toxin A. The term AEO defined as an intermittent inability to open the eyes voluntarily is not a specific entity; it is only a clinical sign whose physiopathological origin is var

Botulinum a toxin for the treatment of s

Botulinum a toxin for the treatment of spasmodic torticollis: Dysphagia and regional toxin spread

✍ Dr. Gary E. Borodic; Michael Joseph; Laurie Fay; David Cozzolino; Mr. Robert J. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 873 KB

Chemodenervation of cervical muscles with botulinum A toxin, although useful in treating spasmodic torticollis, has been associated with dysphagia. Retrospective analysis of dose and injection site (sternomastoid vs. posterior cervical muscle groups) in 26 patients (49 injections) suggested that dys

Reply: Botulinum toxin A injections impr

Reply: Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases

✍ Masato Kanazawa; Takayoshi Shimohata; Masatoyo Nishizawa 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

We have read with interest the letter of Kanazawa 1 about improvement of apraxia of eyelid opening (AEO) with botulinum toxin A. The term AEO defined as an intermittent inability to open the eyes voluntarily is not a specific entity; it is only a clinical sign whose physiopathological origin is var

Botulinum a toxin for the so-called apra

Botulinum a toxin for the so-called apraxia of lid opening

✍ V. Lepore; G. Defazio; D. Acquistapace; C. Melpignano; L. Pomes; P. Lamberti; P. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB

cerebello-cerebral diaschisis, associated with another rare phenomenon, hemidystonia. It raises the question of possible links between hemidystonia and ipsilateral cerebellar injury and provides a new twist to the already complex puzzle of the etiopathological mechanisms underlying dystonia (1 1).

Treatment of idiopathic spasmodic tortic

Treatment of idiopathic spasmodic torticollis with botulinum toxin a: A double-blind study on twenty-three patients

✍ Dr. I. T. Lorentz; S. Shanthi Subramaniam; C. Yiannikas 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 522 KB

In a double-blind, placebo-controlled study, 23 patients suffering from intractable spasmodic torticollis (ST) were given successively either botulinum toxin A (BTA) or normal saline by intramuscular injections in the affected muscles. Evaluation was carried out by three blinded observers, using a c